Short-Term Clinical Outcomes Among Treatment-Experienced HIV-Positive Patients with Early Low Level Viremia

Por Chao, Chun, Tang, Beth, Towner, William, Silverberg, Michael J., Hurley, Leo, Horberg, Michael
Publicado em 2012

CC3-02: Risk Factors for Short-term Virologic Outcomes Among HIV-infected Patients Undergoing Regimen Switch of Combination Antiretroviral Therapy

Por Chao, Chun, Tang, Beth, Hurley, Leo, Silverberg, Michael, Towner, William, Preciado, Melissa, Horberg, Michael
Publicado em 2012

Risk Factors for Short-Term Virologic Outcomes Among HIV-Infected Patients Undergoing Regimen Switch of Combination Antiretroviral Therapy

Por Chao, Chun, Tang, Beth, Hurley, Leo, Silverberg, Michael J, Towner, William, Preciado, Melissa, Horberg, Michael
Publicado em 2012

Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System

Por Marcus, Julia L., Hurley, Leo B., Hare, C. Bradley, Silverberg, Michael J., Volk, Jonathan E.
Publicado no Am J Public Health (2016)

Cytology and Human Papillomavirus Co-Test Results Preceding Incident High-Grade Cervical Intraepithelial Neoplasia

Por Park, Ina U., Wojtal, Nicole, Silverberg, Michael J., Bauer, Heidi M., Hurley, Leo B., Manos, M. Michele
Publicado no PLoS One (2015)

Missed Office Visits and Risk of Mortality Among HIV-Infected Subjects in a Large Healthcare System in the United States

Por Horberg, Michael A., Hurley, Leo B., Silverberg, Michael J., Klein, Daniel B., Quesenberry, Charles P., Mugavero, Michael J.
Publicado em 2013

Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy

Por Kantor, Rami, Shafer, Robert W., Follansbee, Stephen, Taylor, Jonathan, Shilane, David, Hurley, Leo, Nguyen, Dong-Phuong, Katzenstein, David, Fessel, W. Jeffrey
Publicado em 2004

Influence of provider experience on antiretroviral adherence and viral suppression

Por Horberg, Michael A, Hurley, Leo B, Towner, William J, Allerton, Michael W, Tang, Beth T, Catz, Sheryl L, Silverberg, Michael J, Quesenberry, Charles P
Publicado em 2012

Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation

Por Marcus, Julia L., Hurley, Leo B., Hare, Charles Bradley, Nguyen, Dong Phuong, Phengrasamy, Tony, Silverberg, Michael J., Stoltey, Juliet E., Volk, Jonathan E.
Publicado no J Acquir Immune Defic Syndr (2016)

N88D Facilitates the Co-occurrence of D30N and L90M and the Development of Multidrug Resistance in HIV Type 1 Protease following Nelfinavir Treatment Failure

Por MITSUYA, YUMI, WINTERS, MARK A., FESSEL, W. JEFFREY, RHEE, SOO-YON, HURLEY, LEO, HORBERG, MICHAEL, SCHIFFER, CELIA A., ZOLOPA, ANDREW R., SHAFER, ROBERT W.
Publicado em 2006

HIV-1 Drug Resistance Genotype Results in Patients With Plasma Samples With HIV-1 RNA Levels Less Than 75 Copies/mL

Por Mitsuya, Yumi, Winters, Mark A., Fessel, W. Jeffrey, Rhee, Soo-Yon, Slome, Sally, Flamm, Jason, Horberg, Michael, Hurley, Leo, Klein, Daniel, Shafer, Robert W.
Publicado em 2006

Response to Therapy in Antiretroviral Therapy–Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor–Associated Transmitted Drug Resistance

Por Clutter, Dana S., Fessel, W. Jeffrey, Rhee, Soo-Yon, Hurley, Leo B., Klein, Daniel B., Ioannidis, John P. A., Silverberg, Michael J., Shafer, Robert W.
Publicado no J Acquir Immune Defic Syndr (2016)

Determination of Optimized Multidisciplinary Care Team for Maximal Antiretroviral Therapy Adherence

Por Horberg, Michael Alan, Hurley, Leo Bartemeier, Towner, William James, Allerton, Michael Warren, Tang, Beth Ting-Ting, Catz, Sheryl Lynn, Silverberg, Michael Jonah, Quesenberry, Charles Price
Publicado em 2012

Racial/Ethnic and Socioeconomic Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus in an Insured Population

Por Marcus, Julia, Hurley, Leo, Chamberland, Scott, Champsi, Jamila, Gittleman, Laura, Korn, Daniel, Lai, Jennifer, Quesenberry, Charles, Ready, Joanna, Saxena, Varun, Seo, Suk, Witt, David, Silverberg, Michael
Publicado no Open Forum Infect Dis (2017)

The Effect of HIV Infection, Immunodeficiency and Antiretroviral Therapy on the Risk of Hepatic Dysfunction

Por Towner, William J., Xu, Lanfang, Leyden, Wendy A., Horberg, Michael A., Chao, Chun R., Tang, Beth, Klein, Daniel B., Hurley, Leo B., Quesenberry, Charles P., Silverberg, Michael J.
Publicado em 2012

HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance

Por Rhee, Soo-Yon, Fessel, W. Jeffrey, Zolopa, Andrew R., Hurley, Leo, Liu, Tommy, Taylor, Jonathan, Nguyen, Dong Phuong, Slome, Sally, Klein, Daniel, Horberg, Michael, Flamm, Jason, Follansbee, Stephen, Schapiro, Jonathan M., Shafer, Robert W.
Publicado em 2005

Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms

Por Rhee, Soo-Yon, Fessel, W. Jeffrey, Liu, Tommy F., Marlowe, Natalia M., Rowland, Charles M., Rode, Richard A., Vandamme, Anne-Mieke, Laethem, Kristel Van, Brun-Vezinet, Francçoise, Calvez, Vincent, Taylor, Jonathan, Hurley, Leo, Horberg, Michael, Shafer, Robert W.
Publicado no J Infect Dis (2009)